Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince a judge to sign off on its third attempt to resolve thousands of lawsuits through a subsidiary's bankruptcy.

Johnson & Johnson is beginning its third legal battle over its baby powder product's alleged link to ovarian cancer in more than 62,000 women across the country in a $10 billion case